Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 15;61 Suppl 8(Suppl 8):S785-801.
doi: 10.1093/cid/civ731.

Management of Gonorrhea in Adolescents and Adults in the United States

Sarah Kidd  1 , Kimberly A Workowski  2
Affiliations

Management of Gonorrhea in Adolescents and Adults in the United States

Sarah Kidd et al. Clin Infect Dis. .

Abstract

Gonorrhea is the second most commonly reported notifiable disease in the United States and is associated with serious health sequelae, including pelvic inflammatory disease, infertility, and ectopic pregnancy. Treatment for gonorrhea has been complicated by antimicrobial resistance. Neisseria gonorrhoeae has developed resistance to each of the antimicrobials that were previously recommended as first-line treatment regimens, and current treatment options are severely limited. This article summarizes the key questions and data that were discussed at the Sexually Transmitted Diseases (STD) Treatment Guidelines Expert Consultation meeting in April 2013, and the rationale for the 2015 Centers for Disease Control and Prevention STD treatment guidelines for gonococcal infections in adolescents and adults. Key issues addressed include whether to change the dosage of ceftriaxone and azithromycin used in the recommended dual treatment regimen, whether to continue to list dual treatment with cefixime and azithromycin as an alternative treatment regimen, and management of gonococcal infections in persons with severe cephalosporin allergy or suspected treatment failure.

Keywords: Neisseria gonorrhoeae; drug therapy; gonorrhea.

PubMed Disclaimer

Conflict of interest statement

Potential conflict of interest. Both authors: No reported conflicts.

Both authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

    1. Adams DA, Jajosky RA, Ajani U, et al. Summary of notifiable diseases—United States, 2012. MMWR Morb Mortal Wkly Rep 2014; 61:1–121. - PubMed
    1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2013. Atlanta, GA: US Department of Health and Human Services, 2014.
    1. Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013; 40:187–93. - PubMed
    1. Hook EW, Handsfield HH. Gonococcal infections in the adult In: Holmes KK, Sparling PF, Stamm WE, et al. eds. Sexually transmitted diseases. 4th ed. McGraw-Hill, 2008:627–45.
    1. Unemo M, Shafer W. Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci 2011; 1230:E19–28. - PMC - PubMed